Remetinostat
≥98%
- Product Code: 102276
CAS:
946150-57-8
| Molecular Weight: | 323.34 g./mol | Molecular Formula: | C₁₆H₂₁NO₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Remetinostat is primarily used in the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin lymphoma that affects the skin. It functions as a histone deacetylase (HDAC) inhibitor, which helps regulate gene expression and can induce cancer cell death. The compound is applied topically, making it a convenient option for targeting skin lesions directly while minimizing systemic side effects. Its localized action is particularly beneficial for patients with early-stage CTCL, offering a non-invasive treatment alternative to systemic therapies. Clinical studies have shown promising results in reducing lesion size and improving skin symptoms, making it a potential therapeutic option for managing this condition.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | Ft165,619.59 |
+
-
|
| 0.010 | 10-20 days | Ft254,926.17 |
+
-
|
Remetinostat
Remetinostat is primarily used in the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin lymphoma that affects the skin. It functions as a histone deacetylase (HDAC) inhibitor, which helps regulate gene expression and can induce cancer cell death. The compound is applied topically, making it a convenient option for targeting skin lesions directly while minimizing systemic side effects. Its localized action is particularly beneficial for patients with early-stage CTCL, offering a non-invasive treatment alternative to systemic therapies. Clinical studies have shown promising results in reducing lesion size and improving skin symptoms, making it a potential therapeutic option for managing this condition.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :